Who invested in Quince Therapeutics?
Quince Therapeutics's investors include Sequoia Capital and Cormorant Asset Management.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$137Mraised across 2 rounds since 2025, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $115M sold
From Quince Therapeutics's own website.
AdvisersJune Bray
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Quince Therapeutics's investors include Sequoia Capital and Cormorant Asset Management.
Quince Therapeutics has raised $137M across 2 rounds since 2025.
Quince Therapeutics's most recent round was an Undisclosed round of $115M in May 2026.
Its most recent round, $115M in May 2026, is also its largest on record.
Quince Therapeutics's first round on record, in Jun 2025, was backed by Sequoia Capital.
Quince Therapeutics's latest named round is an Undisclosed round, in May 2026.
Quince Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.